Therapeutic effects of statins on osteoarthritis: A review

Shirin Saberianpour1, Samaneh Abolbashari1, Mohamad H S Modaghegh1

  • 1Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Insights

Statins, used for high cholesterol, may prevent osteoarthritis (OA) progression. These drugs, like atorvastatin and simvastatin, show potential chondroprotective and anti-inflammatory effects in joint tissues.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Rheumatology

Background:

  • Osteoarthritis (OA) is a progressive joint disease with multifactorial etiology and limited effective treatments.
  • Hypercholesterolemia is an emerging risk factor for OA development.
  • Statins are HMG-CoA reductase inhibitors used to manage hypercholesterolemia by reducing cholesterol synthesis.

Purpose of the Study:

  • To review the potential therapeutic effects of statins on osteoarthritis.
  • To explore the mechanism by which statins may impact joint cartilage health.

Main Methods:

  • Literature review of studies investigating statins (atorvastatin, simvastatin) in the context of osteoarthritis.
  • Analysis of in vitro and in vivo data on the effects of statins on cartilage degradation and inflammation.

Main Results:

  • Statins, by inhibiting HMG-CoA reductase, reduce cholesterol biosynthesis, potentially preventing OA-related cartilage deterioration.
  • Atorvastatin demonstrated cartilage protection against interleukin-1β-induced degradation and exhibited anti-inflammatory effects via the STAT1-caspase-3 pathway.
  • Simvastatin showed in vitro chondroprotective effects by downregulating matrix metalloproteinases expression.

Conclusions:

  • Statins possess potential preventive and therapeutic properties for osteoarthritis.
  • Further research is warranted to fully elucidate the role of statins in managing OA.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
849
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.4K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
608
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
49